Rock Springs Capital Management as of Dec. 31, 2021
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 136 positions in its portfolio as reported in the December 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Agilon Health (AGL) | 4.7 | $202M | 7.5M | 27.00 | |
Humana (HUM) | 3.7 | $162M | 349k | 463.86 | |
Align Technology (ALGN) | 3.0 | $131M | 200k | 657.18 | |
Intuitive Surgical Com New (ISRG) | 3.0 | $129M | 360k | 359.30 | |
Insulet Corporation (PODD) | 2.9 | $123M | 464k | 266.07 | |
UnitedHealth (UNH) | 2.8 | $121M | 240k | 502.14 | |
IDEXX Laboratories (IDXX) | 2.7 | $119M | 180k | 658.46 | |
Hca Holdings (HCA) | 2.7 | $116M | 450k | 256.92 | |
Argenx Se Sponsored Adr (ARGX) | 2.5 | $110M | 315k | 350.19 | |
Neurocrine Biosciences (NBIX) | 2.2 | $94M | 1.1M | 85.17 | |
Blueprint Medicines (BPMC) | 2.1 | $92M | 860k | 107.11 | |
Agios Pharmaceuticals (AGIO) | 2.0 | $87M | 2.6M | 32.87 | |
Immunocore Hldgs Ads (IMCR) | 2.0 | $85M | 2.5M | 34.24 | |
Horizon Therapeutics Pub L SHS | 1.9 | $80M | 746k | 107.76 | |
Edwards Lifesciences (EW) | 1.7 | $75M | 582k | 129.55 | |
Ultragenyx Pharmaceutical (RARE) | 1.7 | $74M | 884k | 84.09 | |
Zai Lab Adr (ZLAB) | 1.7 | $74M | 1.2M | 62.85 | |
Baxter International (BAX) | 1.5 | $63M | 734k | 85.84 | |
Novavax Com New (NVAX) | 1.4 | $61M | 425k | 143.07 | |
Mirati Therapeutics | 1.4 | $60M | 410k | 146.69 | |
Pacira Pharmaceuticals (PCRX) | 1.4 | $60M | 1.0M | 60.17 | |
Nevro (NVRO) | 1.3 | $58M | 714k | 81.07 | |
Evolent Health Cl A (EVH) | 1.3 | $56M | 2.0M | 27.67 | |
Alnylam Pharmaceuticals (ALNY) | 1.3 | $56M | 333k | 169.58 | |
Aclaris Therapeutics (ACRS) | 1.3 | $56M | 3.9M | 14.54 | |
Karuna Therapeutics Ord | 1.3 | $56M | 427k | 131.00 | |
Freshpet (FRPT) | 1.3 | $55M | 580k | 95.27 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $54M | 400k | 134.53 | |
Cerevel Therapeutics Hldng I (CERE) | 1.2 | $53M | 1.6M | 32.42 | |
Irhythm Technologies (IRTC) | 1.2 | $51M | 433k | 117.69 | |
Kymera Therapeutics (KYMR) | 1.1 | $47M | 742k | 63.49 | |
Acadia Healthcare (ACHC) | 1.0 | $45M | 749k | 60.70 | |
EXACT Sciences Corporation (EXAS) | 1.0 | $44M | 570k | 77.83 | |
Invitae (NVTAQ) | 1.0 | $43M | 2.8M | 15.27 | |
Penumbra (PEN) | 1.0 | $43M | 149k | 287.32 | |
Shockwave Med | 0.9 | $40M | 223k | 178.33 | |
Seagen | 0.9 | $40M | 256k | 154.60 | |
Sarepta Therapeutics (SRPT) | 0.9 | $38M | 424k | 90.05 | |
Arvinas Ord (ARVN) | 0.9 | $38M | 457k | 82.14 | |
Cytokinetics Note 4.000%11/1 (Principal) | 0.8 | $36M | 8.0M | 4.46 | |
Warby Parker Cl A Com (WRBY) | 0.8 | $34M | 724k | 46.56 | |
Health Catalyst (HCAT) | 0.8 | $34M | 850k | 39.62 | |
Verve Therapeutics (VERV) | 0.8 | $33M | 903k | 36.87 | |
Covetrus | 0.8 | $33M | 1.7M | 19.97 | |
Encompass Health Corp (EHC) | 0.8 | $33M | 503k | 65.26 | |
Phreesia (PHR) | 0.7 | $32M | 770k | 41.66 | |
Prothena Corp SHS (PRTA) | 0.7 | $32M | 648k | 49.40 | |
Accolade (ACCD) | 0.7 | $32M | 1.2M | 26.36 | |
Dex (DXCM) | 0.7 | $31M | 57k | 536.95 | |
Travere Therapeutics (TVTX) | 0.7 | $30M | 952k | 31.04 | |
Abcam Ads | 0.7 | $30M | 1.3M | 23.55 | |
CONMED Corporation (CNMD) | 0.7 | $29M | 203k | 141.76 | |
Graphite Bio | 0.6 | $26M | 2.1M | 12.43 | |
Sierra Oncology Com New | 0.6 | $26M | 1.2M | 21.74 | |
Intersect Ent | 0.6 | $26M | 940k | 27.31 | |
Mirum Pharmaceuticals (MIRM) | 0.6 | $25M | 1.5M | 15.95 | |
Prometheus Biosciences | 0.6 | $25M | 618k | 39.54 | |
Xenon Pharmaceuticals (XENE) | 0.6 | $24M | 771k | 31.24 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $23M | 264k | 88.35 | |
Madrigal Pharmaceuticals (MDGL) | 0.5 | $23M | 269k | 84.74 | |
Pulmonx Corp (LUNG) | 0.5 | $22M | 700k | 32.07 | |
Dynavax Technologies Corp Com New (DVAX) | 0.5 | $22M | 1.6M | 14.07 | |
West Pharmaceutical Services (WST) | 0.5 | $21M | 46k | 469.01 | |
Mersana Therapeutics (MRSN) | 0.5 | $20M | 3.2M | 6.22 | |
Guardant Health (GH) | 0.5 | $20M | 200k | 100.02 | |
Xilio Therapeutics (XLO) | 0.4 | $19M | 1.2M | 16.00 | |
Lifestance Health Group (LFST) | 0.4 | $19M | 2.0M | 9.52 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.4 | $19M | 404k | 46.61 | |
Anaptysbio Inc Common (ANAB) | 0.4 | $19M | 539k | 34.75 | |
Relay Therapeutics (RLAY) | 0.4 | $18M | 598k | 30.71 | |
Immuneering Corp Class A Com (IMRX) | 0.4 | $18M | 1.1M | 16.17 | |
Aura Biosciences (AURA) | 0.4 | $17M | 1.0M | 16.98 | |
Compass Therapeutics (CMPX) | 0.4 | $17M | 5.3M | 3.17 | |
Icosavax | 0.4 | $17M | 736k | 22.88 | |
Spero Therapeutics (SPRO) | 0.3 | $15M | 945k | 16.01 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.3 | $15M | 15M | 0.98 | |
Amarin Corp Spons Adr New (AMRN) | 0.3 | $15M | 4.4M | 3.37 | |
Amryt Pharma Sponsored Ads | 0.3 | $14M | 1.3M | 10.80 | |
Macrogenics (MGNX) | 0.3 | $14M | 857k | 16.05 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $14M | 725k | 18.68 | |
Novocure Ord Shs (NVCR) | 0.3 | $13M | 175k | 75.08 | |
Aadi Bioscience (AADI) | 0.3 | $13M | 539k | 24.15 | |
Rigel Pharmaceuticals Com New | 0.3 | $13M | 4.9M | 2.65 | |
Akero Therapeutics (AKRO) | 0.3 | $12M | 587k | 21.15 | |
Chinook Therapeutics | 0.3 | $12M | 720k | 16.31 | |
Amicus Therapeutics (FOLD) | 0.3 | $12M | 1.0M | 11.55 | |
Leap Therapeutics | 0.3 | $11M | 3.5M | 3.24 | |
Acumen Pharmaceuticals (ABOS) | 0.2 | $11M | 1.6M | 6.76 | |
Aurinia Pharmaceuticals (AUPH) | 0.2 | $11M | 457k | 22.87 | |
Cullinan Oncology (CGEM) | 0.2 | $10M | 646k | 15.43 | |
Orion Acquisition Corp Unit 02/19/2026 | 0.2 | $9.9M | 1.0M | 9.85 | |
Reneo Pharmaceuticals (RPHM) | 0.2 | $9.8M | 1.1M | 8.55 | |
Epizyme | 0.2 | $9.5M | 3.8M | 2.50 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.2 | $9.4M | 515k | 18.20 | |
Nurix Therapeutics (NRIX) | 0.2 | $9.3M | 321k | 28.95 | |
Mereo Biopharma Group Ads (MREO) | 0.2 | $8.9M | 5.6M | 1.60 | |
Biomea Fusion (BMEA) | 0.2 | $8.7M | 1.2M | 7.45 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $8.3M | 2.2M | 3.75 | |
Vincerx Pharma Com New (VINC) | 0.2 | $8.2M | 809k | 10.19 | |
Fulcrum Therapeutics (FULC) | 0.2 | $8.1M | 457k | 17.69 | |
Nkarta (NKTX) | 0.2 | $7.8M | 507k | 15.35 | |
Paratek Pharmaceuticals | 0.2 | $7.6M | 1.7M | 4.49 | |
Aeglea Biotherapeutics | 0.2 | $7.5M | 1.6M | 4.75 | |
Essa Pharma Com New (EPIX) | 0.2 | $7.3M | 511k | 14.20 | |
Spruce Biosciences (SPRB) | 0.2 | $7.2M | 1.6M | 4.46 | |
Athira Pharma (ATHA) | 0.2 | $7.2M | 552k | 13.03 | |
Design Therapeutics (DSGN) | 0.2 | $7.2M | 335k | 21.41 | |
Phasebio Pharmaceuticals | 0.2 | $6.7M | 2.6M | 2.61 | |
Day One Biopharmaceuticals I (DAWN) | 0.1 | $6.4M | 382k | 16.85 | |
Fate Therapeutics (FATE) | 0.1 | $6.4M | 110k | 58.51 | |
Applied Therapeutics (APLT) | 0.1 | $6.3M | 702k | 8.95 | |
Rhythm Pharmaceuticals (RYTM) | 0.1 | $6.3M | 627k | 9.98 | |
Kinnate Biopharma | 0.1 | $6.0M | 340k | 17.72 | |
Inozyme Pharma (INZY) | 0.1 | $5.9M | 869k | 6.82 | |
Compugen Ord (CGEN) | 0.1 | $5.5M | 1.3M | 4.30 | |
Theseus Pharmaceuticals | 0.1 | $5.5M | 437k | 12.68 | |
Gamida Cell SHS | 0.1 | $5.5M | 2.2M | 2.54 | |
Prelude Therapeutics (PRLD) | 0.1 | $4.6M | 369k | 12.45 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.1 | $4.6M | 761k | 5.99 | |
Tempest Therapeutics (TPST) | 0.1 | $4.3M | 824k | 5.28 | |
Fusion Pharmaceuticals | 0.1 | $4.0M | 948k | 4.17 | |
F-star Therapeutics | 0.1 | $3.8M | 752k | 5.02 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $3.6M | 3.3M | 1.10 | |
Acelrx Pharmaceuticals | 0.1 | $3.5M | 6.3M | 0.56 | |
Bcls Acquisition Corp Com Cl A | 0.1 | $3.0M | 309k | 9.80 | |
Shattuck Labs (STTK) | 0.1 | $2.7M | 314k | 8.51 | |
Jiya Acquisition Corp Com Cl A | 0.0 | $2.0M | 206k | 9.77 | |
Poseida Therapeutics I (PSTX) | 0.0 | $2.0M | 290k | 6.81 | |
Imara | 0.0 | $1.9M | 842k | 2.25 | |
Radius Health Note 3.000% 9/0 (Principal) | 0.0 | $1.5M | 1.5M | 0.97 | |
Theravance Biopharma Note 3.250%11/0 (Principal) | 0.0 | $1.5M | 1.5M | 0.97 | |
Atreca Cl A Com (BCEL) | 0.0 | $1.4M | 463k | 3.03 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.26 | |
Pacira Biosciences Note 2.375% 4/0 (Principal) | 0.0 | $1.0M | 1.0M | 1.03 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $556k | 500k | 1.11 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $253k | 134k | 1.89 |